Send this to a friend

New CEO at Phio Pharmaceuticals ramping up R&D

Marlborough startup drugmaker Phio Pharmaceuticals has changed its name, CEO and model as it attempts to become a cancer therapeutics firm. In an interview, Chief Operating Officer Gerrit Dispersyn – poised to become the company’s CEO in March – spoke about the company’s future.
What is the company hoping for from its new CEO?
The company will continue to develop ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media